Chapters Health Just Bet Big on In-Home Palliative Care : While Leaders Warn the Home Health Chassis Can't Carry It

Chapters Health’s affiliation with Housecall Providers highlights the strategic appeal of connecting hospice, home based primary care, and community based palliative care. Yet CMS’s proposed use of the Medicare home health benefit may not support every patient or every element of a longitudinal palliative care model. This article explains the operational and reimbursement tension and shows owners how to evaluate expansion, valuation, and exit readiness. It also provides practical steps for presenting a palliative care opportunity to a buyer.

8/13/20267 min read

Chapters Health System’s completed affiliation with Housecall Providers shows why integrated home based care is attracting strategic attention. At the same time, hospice leaders are warning that the Medicare home health benefit may not be built to support the longitudinal, community based palliative care many patients need.

Quick-Scan Summary

Who this is for

Home health or hospice owners with $2 million to $10 million in annual revenue.
Owners weighing palliative care expansion, a strategic partnership, succession planning, or a sale.
Operators who want to understand how new service lines may affect buyer underwriting, deal multiples, and exit readiness.

Key takeaways

Chapters Health finalized its affiliation with Oregon based Housecall Providers on August 5, 2026.
The affiliation expands access to hospice, advanced illness care, home based primary care, and community based palliative care.
CMS has stated that skilled palliative care services can be furnished and billed under the existing Medicare home health benefit when eligibility requirements are met.
Hospice leaders caution that homebound requirements, skilled care requirements, and episodic service structures may limit access to broader palliative care.
For owners, palliative expansion can create strategic value, but only when the service is clinically sound, financially measurable, and operationally separate from unsupported assumptions about future reimbursement.

Chapters Health and Housecall Providers: A Strategic Signal

On August 5, 2026, Chapters Health System finalized its affiliation with Oregon based Housecall Providers. Housecall Providers offers hospice, advanced illness care, and home based primary care near Portland. Its community based palliative care program has expanded across five Oregon counties.

Chapters Health is a nonprofit system that serves more than 40,000 hospice patients each year through 30 medical organizations and programs. Its operations extend across Florida, Georgia, New York, New Jersey, Maryland, Virginia, and Washington, DC. The organization has also recently expanded into Nevada, California, and Oregon.

Chapters Health President and CEO Andrew Molosky described the affiliation as the alignment of two visionary nonprofit healthcare providers working to create a continuum for patients, caregivers, and families dealing with chronic illness. Housecall Providers CEO Rebecca Ramsay emphasized that the collective mission is intended to ensure community based care continues throughout Oregon.

The strategic message is clear. A home health or hospice agency may be more valuable when it can participate in a broader care continuum. However, the affiliation also demonstrates that building an integrated model requires more than adding a palliative care label to an existing service line.

Why the Home Health Chassis Creates Tension

CMS addressed palliative care in the CY 2027 Home Health PPS Proposed Rule Fact Sheet, CMS-1844-P, issued July 1, 2026.

CMS stated that skilled palliative care services can be furnished and billed under the existing Medicare home health benefit for eligible patients with serious illness. CMS also made clear that this approach is separate from hospice and may support patients earlier in the course of serious illness. The agency plans to provide additional examples through sub regulatory guidance and requested comments on how to promote community based palliative care through existing Medicare benefits.

That clarification may help agencies serve certain eligible patients. It does not create a separate palliative care benefit or resolve the underlying structural concerns.

The home health benefit generally depends on three core concepts:

The patient must meet homebound requirements.
The patient must need skilled care.
Services are typically episodic and intermittent.

Palliative care can require a different structure. Many patients benefit from longitudinal symptom management, care coordination, family support, and regular clinical engagement even when they remain ambulatory, continue working, or participate actively in their communities.

Hospice leaders cited by Hospice News described CMS’s approach as a “limited prospect” because the home health chassis may not support the full interdisciplinary and longitudinal model that community based palliative care requires. Some leaders believe a dedicated community based palliative care benefit would be more appropriate, although creating one could require an act of Congress.

The CY 2026 Home Health PPS Final Rule, CMS-1828-F provides important context. That rule focused on payment updates, PDGM adjustments, quality reporting, value based purchasing, face to face encounter policy, and provider enrollment. It did not establish a dedicated palliative care benefit.

What This Means for an Owner Considering Expansion

Imagine a hospice owner in the $4 million revenue range who has strong clinical leadership and referral relationships but no formal palliative care program. The owner may see CMS’s proposed language as an opportunity to expand.

The opportunity may be real, but the underwriting question is more specific:

Can the agency demonstrate that the program has appropriate patients, compliant documentation, reliable staffing, sustainable reimbursement, and measurable outcomes?

A buyer will want to distinguish between:

A documented service line with repeatable operations.
A pilot program dependent on one physician or one referral source.
A future opportunity that still lacks a clear payment model.

This distinction affects both sale price and deal certainty. A palliative care program may support a stronger strategic narrative, but unsupported projections will not automatically increase EBITDA or a valuation multiple.

The Valuation Math Behind the Decision

Consider an illustrative home health or hospice agency with $600,000 in normalized EBITDA.

At a hypothetical 4.5 times EBITDA multiple, the implied enterprise value would be:

$600,000 × 4.5 = $2.7 million

Now assume the owner invests in a disciplined palliative care expansion that produces an additional $150,000 in sustainable EBITDA. If the agency also reduces key person dependence, improves documentation, and demonstrates stable referral and payer performance, a buyer might underwrite the combined business at a hypothetical 5.5 times multiple:

$750,000 × 5.5 = $4.125 million

The illustrative difference is $1.425 million.

This is not a market quotation or guaranteed result. It shows how operating performance and risk reduction work together. A buyer does not pay a premium simply because an agency offers palliative care. The buyer underwrites the quality, durability, compliance, and financial contribution of that service.

Conversely, if palliative care creates staffing losses, unclear billing practices, poor documentation, or payer concentration, it could reduce EBITDA and create a valuation haircut.

Expansion or Exit Readiness?

For owners deciding between investment and sale, timing matters. Expanding immediately before a transaction may create uncertainty if the program has not yet produced reliable financial results. In some cases, an owner may be better served by strengthening the core agency, documenting the palliative opportunity, and presenting it to a buyer as a defined growth pathway.

The Operating Data Buyers Will Review

Home health owners should track palliative care and core agency performance separately. Monthly reporting should include net reimbursement per completed visit by payer, authorized visits compared with clinically ordered visits, denials and appeal overturn rates, authorization labor hours per 100 Medicare Advantage episodes, days in accounts receivable by payer, EBITDA margin by payer, revenue concentration by individual Medicare Advantage plan, and referral volume by payer and referral source.

These metrics help answer practical buyer questions:

Is the program generating margin or only volume?
Are authorizations consuming too much administrative labor?
Are denials caused by eligibility, documentation, or payer process issues?
Is one Medicare Advantage plan responsible for too much revenue?
Can the agency support longitudinal care without weakening its existing home health operations?
Will the service line continue after the owner exits?

The CMS-1828-F final rule also reminds operators that home health reimbursement remains subject to payment adjustments, PDGM recalibration, quality reporting requirements, and value based purchasing considerations. A palliative expansion should be evaluated within that reimbursement environment, not apart from it.

A Practical Path for Owners

A hospice owner we will call Daniel is considering a palliative care program after several hospital partners ask for earlier support for patients with serious illness. Daniel has the clinical expertise but depends heavily on one medical director and has limited reporting by payer.

His first step should not be rapid expansion. It should be operational preparation:

Define the patient population the agency can serve compliantly.
Separate palliative care revenue and costs from hospice revenue.
Document staffing, visit frequency, escalation protocols, and care coordination.
Measure emergency department visits, hospitalizations, patient goals, and caregiver experience where data is available.
Determine whether current reimbursement covers the full cost of care.
Build a management structure that does not depend entirely on the owner.

This approach preserves both options. Daniel can expand if the economics support it, or he can approach a buyer with a transparent service line and a credible growth opportunity.

So what should you do now?

Do not treat CMS’s proposed language as a guaranteed new revenue stream. Confirm eligibility, documentation, ordering, and billing requirements before scaling.
Run a 90 day service line review. Measure staffing cost, reimbursement, denials, patient volume, referral sources, and outcomes.
Reduce owner dependence. Assign clinical, financial, and referral responsibilities to identifiable leaders.
Prepare for buyer underwriting. Organize service line financials, compliance records, payer data, and a realistic palliative care forecast.

Partner with Senate Healthcare

Senate Healthcare LLC is the buyer and strategic partner pursuing home health or hospice agency acquisitions. We are evaluating agencies that want to grow, plan a succession, or explore a confidential sale while protecting quality care and continuity for patients and families.

A palliative care program does not need to be perfectly mature before you speak with a buyer. What matters is understanding what is working, what remains uncertain, and what resources are needed to build a sustainable model.

If you are considering palliative expansion, a sale, or a strategic partnership, learn more about Senate Healthcare’s acquisition and exit strategy approach. Owners can also review the agency due diligence readiness checklist before beginning a confidential conversation.

Plain-Language Glossary

Palliative care: Care that helps manage symptoms, stress, and quality of life for people with serious illness. It is not the same as hospice.
Home health chassis: The existing Medicare home health rules and operating structure used to deliver covered home health services.
Longitudinal care: Ongoing care delivered over time rather than only during a short episode.
EBITDA: A measure of operating profit before interest, taxes, depreciation, and amortization.
Multiple: A number applied to EBITDA to estimate business value.
Buyer underwriting: The process a buyer uses to test revenue, expenses, risk, compliance, and future cash flow before determining price.
Key person dependence: The risk that an agency relies too heavily on one owner, clinician, referral relationship, or executive.
Service line: A distinct category of care, such as hospice, home health, or palliative care, that can be measured separately.

Resources:

Unlock Your 30-Minute Agency Succession Review

Maybe you're ready to expand your reach, or perhaps it's time to consider your legacy and the future of your business. Either way, it all begins with a conversation. Schedule a confidential, no-obligation call to explore what the future might hold for you and your business.

Complete the form, and we'll reach out for a chat...